- Home
- LNTH vs AES Comparison
LNTH vs AES Comparison
Compare LNTH & AES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LNTH | AES |
|---|---|---|
| Founded | 1956 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 9.6B |
| IPO Year | 2015 | 1991 |
Fundamental Metrics
Financial Performance| Metric | LNTH | AES |
|---|---|---|
| Price | $62.66 | $13.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 11 |
| Target Price | ★ $74.17 | $15.70 |
| AVG Volume (30 Days) | 1.0M | ★ 7.0M |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 5.08% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.39 | 1.46 |
| Revenue | $1,525,933,000.00 | ★ $12,094,000,000.00 |
| Revenue This Year | $0.01 | $1.13 |
| Revenue Next Year | $1.24 | $4.33 |
| P/E Ratio | $26.02 | ★ $9.47 |
| Revenue Growth | ★ 1.95 | N/A |
| 52 Week Low | $47.25 | $9.46 |
| 52 Week High | $111.29 | $15.51 |
Technical Indicators
Market Signals| Indicator | LNTH | AES |
|---|---|---|
| Relative Strength Index (RSI) | 66.21 | 48.48 |
| Support Level | $57.44 | $13.85 |
| Resistance Level | $64.40 | $14.17 |
| Average True Range (ATR) | 2.16 | 0.32 |
| MACD | 0.77 | 0.01 |
| Stochastic Oscillator | 82.52 | 65.73 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About AES The AES Corporation
AES is a global power company that operates in 15 countries. Its generation portfolio totals over 32 gigawatts, including renewable energy (50%), gas (32%), coal (16%), and oil (2%). AES has majority ownership and operates six electric utilities distributing power to more than 2.5 million customers.